Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team’s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.
Location: United States, Massachusetts, Waltham
Employees: 51-200
Total raised: $72M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Saturn Par... | saturnpart... |
| 07.02.2023 | Unorthodox... | unorthodox... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 14.12.2022 | - | $32M | - |
| 03.02.2022 | - | $25M | - |
| 15.04.2021 | - | $15M | - |
Mentions in press and media 6
| Date | Title | Description |
| 14.12.2022 | Third Pole Therapeutics Receives $32M Strategic Equity Investment to Accelerate its Tankless Inhaled Nitric Oxide (iNO) Platform | - |
| 14.12.2022 | Third Pole Therapeutics Receives $32M Strategic Equity Investment to Accelerate its Tankless Inhaled Nitric Oxide (iNO) Platform | WALTHAM, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) — Third Pole Therapeutics, a privately held company developing critical life-sustaining cardio-pulmonary therapies, announced today a $32M equity investment, from a large medical device innovat... |
| 03.02.2022 | Third Pole Therapeutics Closes $25M Financing – eNOfit™ Wearable Device Now Ready for Clinical Trials | – eNOfit™, Third Pole’s novel nitric oxide mobile-wearable device designed to provide “on-the-go” treatment for patients suffering from severe COPD and ILD, to enter clinical trials in the second half of this year |
| 15.04.2021 | Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P. | |
| - | Third Pole | “Third Pole Therapeutics | Heart and Lung Therapy Reimagined” |
| - | Third Pole Therapeutics Expands Board of Directors | WALTHAM, Mass., Feb. 24, 2021 /PRNewswire/ -- Third Pole, Inc., a privately held company developing and delivering critical life-sustaining cardio-pulmonary therapies, announced today that it has added two seasoned pharmaceutical executives... |